Skip to Content

Z 2345 Z 2345 (Procainamide 250 mg)

Pill with imprint Z 2345 Z 2345 is Yellow, Capsule-shape and has been identified as Procainamide hydrochloride 250 mg. It is supplied by Teva Pharmaceuticals USA.

Procainamide is used in the treatment of arrhythmia; myotonia congenita and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Procainamide 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Z 2345 Z 2345

Procainamide hydrochloride

Z 2345 Z 2345
250 mg
18.00 mm
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.